
Doug Long, vice president of industry relations at IMS Health, discusses his predictions for the 2012-2013 flu season.

Doug Long, vice president of industry relations at IMS Health, discusses his predictions for the 2012-2013 flu season.

Several melanoma experts discuss new treatments for the condition, including vemurafenib (Zelboraf) and ipilimumab (Yervoy).

Isaac Brownell, MD, PhD, of Memorial Sloan-Kettering Cancer Center, discusses means of preventing and detecting skin cancers, including basal cell carcinoma, squamous cell carcinoma, and melanoma.












Dana Goldman, PhD discusses the results of a Journal of the American Medical Association study analyzing the effects of cost increases in children's asthma medication.













